Free Trial
EPA:DIM

Sartorius Stedim Biotech (DIM) Stock Price, News & Analysis

Sartorius Stedim Biotech logo
€204.00 -1.10 (-0.54%)
As of 07/3/2025

About Sartorius Stedim Biotech Stock (EPA:DIM)

Key Stats

Today's Range
€203.10
€207.30
50-Day Range
€189.50
€213.20
52-Week Range
N/A
Volume
29,677 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

DIM Stock News Headlines

Something very strange is happening...
What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone noticed when the U.S. Senate granted sweeping powers to a Harvard economist who has some dangerous ideas about the U.S. dollar. Now, he's issued a blueprint for what a coming "Mar-a-Lago Accord" could look like. One analyst who predicted the 2008 crisis says this plan could see the dollar fall in value by 40% in months and become a national nightmare.
Sartorius Stedim Biotech S.A. - Barron's
See More Headlines

DIM Stock Analysis - Frequently Asked Questions

Sartorius Stedim Biotech's stock was trading at €188.70 at the beginning of 2025. Since then, DIM stock has increased by 8.1% and is now trading at €204.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Corbus Pharmaceuticals (CRBP), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and C3.ai (AI).

Industry, Sector and Symbol

Stock Exchange
EPA
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
EPA:DIM
CIK
N/A
Fax
N/A
Employees
10,493
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (EPA:DIM) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners